DONA®
Natural health product licensed in Canada
- Other names
- DONA® Crystalline Glucosamine Sulfate
- Licence holder
- Auro Pharma Inc.
- NPN or DIN-HM
- 80096645
- Status
- Active licence
- Licence date
- 15 January 2020
- Revision date
- 12 April 2022
- Form
- Comprimé, enrobé par pellicule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Exosquelette de crabe | 750 mg | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Exosquelette de crevette | 750 mg | Not calculated |
Non-medicinal ingredients
NA, Talc, Maltodextrine, Poly(dextrose), Macrogol 6 000, Croscarmellose de sodium, Stéarate de magnésium, Cellulose microcristalline, Polyvinylpyrrolidone, Hypromellose, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
A factor in maintaining good cartilage and/or joint health. Helps protect against the deterioration of cartilage and relieve joint pain associated with osteoarthritis. Helps to protect against the deterioration of cartilage. Helps to relieve joint pain associated with osteoarthritis. Helps to relieve pain associated with osteoarthritis of the knee.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner/health care provider/health care professional/doctor/ physician if symptoms worsen. Consult a health care practitioner/health care provider/health care professional/doctor/ physician prior to use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80096645
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging